“…[aH]-dynorphin, injected intracerebrally, is converted to SH-tyrosine and des-Tyrdynorphin with exceptional rapidity [41]. Therefore, most studies of the behavioral effects of intracerebral dynorphin may have actually been studies of potent nonopioid metabolite(s), especially des-Tyr-dynorphin [8,14,16,17,28,29,33,35,36]. One approach to inhibiting the metabolism of opioid peptides is the substitution of D-alanine in position 2 [3,4,27,32,34].…”